RecruitingNot Applicable

Effect OF Lactase Enzyme Supplements ON Intolerance IN Preterm Neonates

Egypt120 participantsStarted 2025-08-30

Plain-language summary

This study aims to study the effect of lactase enzyme in preventing feeding intolerance in preterm neonates in neonatal intensive care unit at Alexandria University Children's Hospital.

Who can participate

Age range3 Days – 1 Month

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Exclusion criteria

✕. Parental consent lacking/refusal.
✕. Obvious major congenital abnormalities.
✕. Infants more than 72 hours of age at the time of randomization.
✕. Delayed introduction of feeding (beyond three days of life).
✕. Known galactosemia.
✕. Severe IUGR. -

What they're measuring

Feeding intolerance:

Timeframe: first two weeks of life

Trial details

NCT IDNCT07088302

SponsorAlexandria University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-02-28

Contact for this trial

Marwa M Farag, PhD

01288681788 d.marwa.farag@gmail.com

View on ClinicalTrials.gov More Premature trials